Table 2.

Antitumor effect of GLY in murine WEHI-3 leukemia model.

Organs	Groups
	Normal control	Untreated group	0.75 g/kg GLY	1.5 g/kg GLY
Tumor		0.57 ± 0.27	0.22 ± 0.07d	0.21 ± 0.08c
Liver	1.45 ± 0.08	1.64 ± 0.06a	1.48 ± 0.08c	1.47 ± 0.05d
Spleen	0.09 ± 0.01	0.14 ± 0.03b	0.14 ± 0.02	0.11 ± 0.02c

Data was presented as grams weight and expressed as the mean ± SD (n = 7). GLY extract was orally administered one time daily for 14 days. Results: ^a P < 0.05 versus normal control (without tumor graft), ^b P < 0.01 versus normal control, ^c P < 0.05 versus untreated group (tumor graft alone), and ^d P < 0.01 versus untreated group.